REGISTERED AND RENEWED
on 13 May 2024
Last Applicant/ Owned by
4960 Peachtree Industrial Boulevard
Norcross
GA
30071
Serial Number
85873661 filed on 12th Mar 2013
Registration Number
4492469 registered on 04th Mar 2014
Correspondent Address
Joseph Agostino
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
GALECTIN THERAPEUTICS GT
Pharmaceutical preparations, namely, compounds for use in the treatment of nonalcoholic steatohepatitis, fibrosis, inflammatory and autoimmune disorders, neoplastic conditions, cancer, liver fibrosis, kidney fibrosis, lung fibrosis and/or heart fibrosis
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations, namely, compounds for use in the treatment of nonalcoholic steatohepatitis, fibrosis, inflammatory and autoimmune disorders, neoplastic conditions, cancer, liver fibrosis, kidney fibrosis, lung fibrosis and/or heart fibrosis
First Use Date in General
27th Jun 2013
First Use Date in Commerce
27th Jun 2013
Mark Details
Serial Number
No 85873661
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 08991802810
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.09.21 -
Squares that are completely or partially shaded
Legal History
| Status Date | Action Taken |
|---|---|
| 13th May 2024 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| 13th May 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
| 13th May 2024 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| 13th May 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 26th Jan 2024 | TEAS SECTION 8 & 9 RECEIVED |
| 04th Mar 2023 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| 05th Jun 2020 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| 05th Jun 2020 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 05th Jun 2020 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 06th Apr 2020 | POST REGISTRATION ACTION MAILED - SEC. 8 & 15 |